Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Cervicofacial actinomycosis

Abdu A Sharkawy, MD, FRCPC
Anthony W Chow, MD, FRCPC, FACP
Section Editor
Stephen B Calderwood, MD
Deputy Editor
Anna R Thorner, MD


Cervicofacial actinomycosis is a chronic disease characterized by abscess formation, draining sinus tracts, fistulae, and tissue fibrosis. It can mimic a number of other conditions, particularly malignancy and granulomatous disease, and should be included in the differential diagnosis of any soft tissue swelling in the head and neck. Cervicofacial involvement is the most common manifestation of actinomycosis, accounting for 50 percent of all cases, while central nervous system, thoracic, abdominal, and pelvic actinomycosis occur less frequently [1,2].

Cervicofacial actinomycosis will be reviewed here. Ileocecal actinomycosis and actinomycosis related to intrauterine devices are discussed separately. (See "Abdominal actinomycosis" and "Intrauterine contraception: Devices, candidates, and selection".)


Cervicofacial actinomycosis is caused by branching gram-positive bacteria belonging to the order Actinomycetales, family Actinomycetaceae, genus Actinomyces [3]. Of note, both Mycobacteria and Nocardia species also belong to the same order, and infections caused by these microbes may at times be difficult to distinguish from Actinomyces [3]. Actinomycosis was originally described in 1878 by Israel [4] and later by Wolfe [5], who isolated the causative organism and defined its anaerobic nature [6].

Actinomyces are non-spore-forming, strict or facultative anaerobes with a variable cellular morphology, ranging from diphtheroidal to coccoid filaments (picture 1). They are normal constituents of the oral flora within gingival crevices and tonsillar crypts and are particularly prevalent in periodontal pockets, dental plaques, and on carious teeth [3]. (See "Deep neck space infections".)

Distinguishing features from fungi — The name actinomycosis literally translates as "ray fungus" and reflects its filamentous, fungal-like characteristic appearance in infected tissues. However, Actinomyces are true bacteria with filaments much narrower than fungal hyphae. While actinomycotic filaments readily fragment into bacillary forms, tubular hyphae of molds never fragment and exhibit distinct branching patterns. Another distinguishing feature between actinomyces and fungi is the method of reproduction, which occurs by binary fission in Actinomyces and not by spore formation or budding as in fungi [3].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Jul 21, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Kwartler JA, Limaye A. Pathologic quiz case 1. Cervicofacial actinomycosis. Arch Otolaryngol Head Neck Surg 1989; 115:524.
  2. Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015; 28:419.
  3. Lerner PI. The lumpy jaw. Cervicofacial actinomycosis. Infect Dis Clin North Am 1988; 2:203.
  4. Israel J. Neve beobactungen anf dem bebiete der mykosen des menshen. Virchows Arch Pathologische Anatomie 1878; 74:15.
  5. Wolfe M, Israel J. Ueber reincultur des actinomyces and seine uebertragbarkeit auf thiere. Virchows Arch Pathologische Anatomie 1891; 126:11.
  6. Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis 1998; 26:1255.
  7. Euzéby JP. List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet. Int J Syst Bacteriol 1997; 47:590.
  8. Schaal KP, Lee HJ. Actinomycete infections in humans--a review. Gene 1992; 115:201.
  9. Lawson PA, Nikolaitchouk N, Falsen E, et al. Actinomyces funkei sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 2001; 51:853.
  10. Nikolaitchouk N, Hoyles L, Falsen E, et al. Characterization of Actinomyces isolates from samples from the human urogenital tract: description of Actinomyces urogenitalis sp. nov. Int J Syst Evol Microbiol 2000; 50 Pt 4:1649.
  11. Funke G, von Graevenitz A. Infections due to Actinomyces neuii (former "CDC coryneform group 1" bacteria). Infection 1995; 23:73.
  12. Belmont MJ, Behar PM, Wax MK. Atypical presentations of actinomycosis. Head Neck 1999; 21:264.
  13. Jacobs RF, Schutze GE. Actinomycosis. In: Nelson Textbook of Pediatrics, 16th ed, Behrman RE (Ed), WB Saunders, Philadelphia 2000. p.823.
  14. Holm P. The "other" microbes of actinomycosis and their importance. Acta Pathol Microbiol Scand 1950; 27:743.
  15. HOLM P. Studies on the aetiology of human actinomycosis. II. Do the other microbes of actinomycosis possess virulence? Acta Pathol Microbiol Scand 1951; 28:391.
  17. Hotchi M, Schwarz J. Characterization of actinomycotic granules by architecture and staining methods. Arch Pathol 1972; 93:392.
  18. Feder HM Jr. Actinomycosis manifesting as an acute painless lump of the jaw. Pediatrics 1990; 85:858.
  19. Kolm I, Aceto L, Hombach M, et al. Cervicofacial actinomycosis: a long forgotten infectious complication of immunosuppression - report of a case and review of the literature. Dermatol Online J 2014; 20:22640.
  20. Atespare A, Keskin G, Erçin C, et al. Actinomycosis of the tongue: a diagnostic dilemma. J Laryngol Otol 2006; 120:681.
  21. Burns BV, al-Ayoubi A, Ray J, et al. Actinomycosis of the posterior triangle: a case report and review of the literature. J Laryngol Otol 1997; 111:1082.
  22. Schaal KP, Beaman BL. Clinical significance of actinomycetes. In: The Biology of the Actinomycetes, Goodfellow M, Mordarski M, Williams ST (Eds), Academic Press, New York 1983. Vol 389.
  23. Kaplan I, Hirshberg A, Shlomi B, et al. The importance of histopathological diagnosis in the management of lesions presenting as peri-implantitis. Clin Implant Dent Relat Res 2015; 17 Suppl 1:e126.
  24. Anavi-Lev K, Anavi Y, Chaushu G, et al. Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115:660.
  25. Mabeza GF, Macfarlane J. Pulmonary actinomycosis. Eur Respir J 2003; 21:545.
  26. Woo HJ, Bae CH, Song SY, et al. Actinomycosis of the paranasal sinus. Otolaryngol Head Neck Surg 2008; 139:460.
  27. Kalioras V, Thanos L, Mylona S, et al. Scalp actinomycosis mimicking soft tissue mass. Dentomaxillofac Radiol 2006; 35:117.
  28. Rankow RM, Abraham DM. Actinomycosis: masquerader in the head and neck. Ann Otol Rhinol Laryngol 1978; 87:230.
  29. PEABODY JW Jr, SEABURY JH. Actinomycosis and nocardiosis. A review of basic differences in therapy. Am J Med 1960; 28:99.
  30. Lo Muzio L, Favia G, Lacaita M, et al. The contribution of histopathological examination to the diagnosis of cervico-facial actinomycosis: a retrospective analysis of 68 cases. Eur J Clin Microbiol Infect Dis 2014; 33:1915.
  31. Kuyama K, Fukui K, Ochiai E, et al. Identification of the actinomycete 16S ribosomal RNA gene by polymerase chain reaction in oral inflammatory lesions. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116:485.
  32. De Vreese K, Verhaegen J. Identification of coryneform Actinomyces neuii by MALDI-TOF MS: 5 case reports and review of literature. Acta Clin Belg 2013; 68:210.
  33. Lerner PI. Serologic screening for actinomycosis. In: Anaerobic Bacteria: Role in Disease, Balows A, (Eds), Charles C. Thomas, Springfield, IL 1974. p.571.
  34. Martin MV. The use of oral amoxycillin for the treatment of actinomycosis. A clinical and in vitro study. Br Dent J 1984; 156:252.
  35. SPILSBURY BW, JOHNSTONE FR. The clinical course of actinomycotic infections: a report of 14 cases. Can J Surg 1962; 5:33.
  36. Nielsen PM. Acute cervico-facial actinomycosi. Int J Oral Maxillofac Surg 1987; 156:252.
  37. Gilbert DN, Moellering RC Jr, Sande MA. The Sanford Guide to Antimicrobial Therapy. Antimicrobial Therapy, Inc 2001; 31:70.
  38. Lerner PI. Susceptibility of pathogenic actinomycetes to antimicrobial compounds. Antimicrob Agents Chemother 1974; 5:302.
  39. Martin MV. Antibiotic treatment of cervicofacial actinomycosis for patients allergic to penicillin: a clinical and in vitro study. Br J Oral Maxillofac Surg 1985; 23:428.
  40. Tanaka-Bandoh K, Watanabe K, Kato N, Ueno K. Susceptibilities of Actinomyces species and Propionibacterium propionicus to antimicrobial agents. Clin Infect Dis 1997; 25 Suppl 2:S262.
  41. Smego RA Jr. Actinomycosis. In: Infectious Diseases, Hoeprich PD, Jordan MC, Ronald AR (Eds), Lippincott, New York 1994. p.493.
  42. Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope 1984; 94:1198.